This Article Full Text Full Text (PDF) Other Versions of this Article: IAI.00324-08v1 76/10/4538    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Google Scholar Articles by Kwok, W. W. Articles by Roti, M. PubMed PubMed Citation Articles by Kwok, W. W. Articles by Roti, M.

 Previous Article  |  Next Article 

Infection and Immunity, October 2008, p. 4538-4545, Vol. 76, No. 10
0019-9567/08/$08.00+0     doi:10.1128/IAI.00324-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

The Anthrax Vaccine Adsorbed Vaccine Generates Protective Antigen (PA)-Specific CD4⁺ T Cells with a Phenotype Distinct from That of Naïve PA T Cells

Benaroya Research Institute at Virginia Mason, 1201 Ninth Ave., Seattle, Washington 98101,¹ Department of Immunology, University of Washington, Seattle, Washington 98195,² Madigan Army Medical Center, Tacoma, Washington 98431³

Received 11 March 2008/ Returned for modification 14 May 2008/ Accepted 24 July 2008

Cellular immune responses against protective antigen (PA) of Bacillus anthracis in subjects that received the anthrax vaccine adsorbed (AVA) vaccine were examined. Multiple CD4⁺ T-cell epitopes within PA were identified by using tetramer-guided epitope mapping. PA-reactive CD4⁺ T cells with a CD45RA^– phenotype were also detected by direct ex vivo staining of peripheral blood mononuclear cells (PBMC) with PA-specific tetramers. Surprisingly, PA-specific T cells were also detected in PBMC of nonvaccinees after a single cycle of in vitro PA stimulation. However, PA-reactive CD4⁺ T cells in nonvaccinees occurred at lower frequencies than those in vaccinees. The majority of PA-reactive T cells from nonvaccinees were CD45RA⁺ and exhibited a Th0/Th1 cytokine profile. In contrast, phenotyping and cytokine profile analyses of PA-reactive CD4⁺ T cells from vaccinees indicated that vaccination leads to commitment of PA-reactive T cells to a Th2 lineage, including generation of PA-specific, pre-Th2 central memory T cells. These results demonstrate that the current AVA vaccine is effective in skewing the development of PA CD4⁺ T cells to the Th2 lineage. The data also demonstrated the feasibility of using class II tetramers to analyze CD4⁺ cell responses and lineage development after vaccination.

Published ahead of print on 4 August 2008.

Editor: S. R. Blanke